Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention

BACKGROUND: During the COVID pandemic, overall buprenorphine treatment appeared to remain relatively stable, despite some studies suggesting a decrease in patients starting buprenorphine. There is a paucity of empirical information regarding patterns of buprenorphine treatment during the pandemic. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Bradley D., Landis, Rachel K., Sheng, Flora, Saloner, Brendan, Gordon, Adam J., Sorbero, Mark, Dick, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734477/
https://www.ncbi.nlm.nih.gov/pubmed/36474004
http://dx.doi.org/10.1007/s11606-022-07891-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734477/
https://www.ncbi.nlm.nih.gov/pubmed/36474004
http://dx.doi.org/10.1007/s11606-022-07891-w

Ejemplares similares